ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 763059 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 763059; 2) Community: the network communities that were significantly associated with the response to NSC 763059; 3) Molecule: the relationships between components within communities and NSC 763059; 4) MDR: the compounds that were significantly associated with the NSC 763059.

NSC Compound Enrichment Correlation
NSC 165572 Pyrido[3,2-g]quinoline-2,5,8,10(1H,9H)-tetrone, 1,4,6-trimethyl- 0.0430505868034761 -0.059728584
NSC 168516 Benzene, 1,1'-(1,2-ethanediyl)bis[2,5-dimethoxy- 0.0430505868034761 0.24982284
NSC 176328 Ellipticine, 6-(3-aminopropyl)-, dihydrochloride 0.0430505868034761 0.24369511
NSC 292816 1-Butanone, 1,1'-(9-ethyl-9H-carbazole-3,6-diyl)bis[4-(dimethylamino)-, (E)-2-butenedioate (1:1) 0.0430505868034761 0.19373693
NSC 295499 Camptothecin Derivative 0.0430505868034761 0.026105744
NSC 330507 Tanespimycin 0.0430505868034761 0.22848722
NSC 337851 Pregna-1,4-diene-3,11,20-trione, 21-[[[[3,6-bis(dimethylamino)-9-acridinyl]thio]acetyl]oxy]-17-hydroxy- 0.0430505868034761 0.34102881
NSC 349174 Oxanthrazole 0.0430505868034761 -0.046425668
NSC 354975 1,2-Didemethylcolchicine 0.0430505868034761 0.21967538
NSC 355644 Anthrapyrazole derivative 0.0430505868034761 -0.086404197
Total:116  Current:102    [First] [Prev] [Next] [Last]